MFDS active in supping development of Alzheimer-type dementia treatments

Published: 2017-08-28 14:42:45

Updated: 2017-08-28 14:42:45

While the pharmaceutical industry has been active in developing combination drugs improved in safety and effectiveness, the Ministry of Food and Drug Safety(MFDS) will support pharmaceutical companies for development of combination medicines for the treatment of dementia.

According to the MFDS, about a half of 82 products approved as incrementally modified drug, 42 of them were reportedly medi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.